Enrofloxacin: Difference between revisions
m (Protected "Enrofloxacin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +)) |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
'''Enrofloxacin''' is a [[fluoroquinolone]] antibiotic sold by the [[Bayer|Bayer Corporation]] under the trade name '''Baytril'''. Enrofloxacin is currently [[Food and Drug Administration|FDA]]-approved for treatment of individual pets and domestic animals in the United States. In September of 2005, the FDA withdrew approval of Baytril for use in water to treat flocks of poultry, as this practice was noted to promote the evolution of fluoroquinolone-resistant strains of the bacterium ''[[Campylobacter]]'', a human pathogen.<ref>http://www.fda.gov/cvm/FQWithdrawal.html FDA statement on withdrawal of Baytril for use in poultry</ref> Fluoroquinolones such as [[ciprofloxacin]] are widely used in the treatment of human disease. | '''Enrofloxacin''' is a [[fluoroquinolone]] antibiotic sold by the [[Bayer|Bayer Corporation]] under the trade name '''Baytril'''. Enrofloxacin is currently [[Food and Drug Administration|FDA]]-approved for treatment of individual pets and domestic animals in the United States. In September of 2005, the FDA withdrew approval of Baytril for use in water to treat flocks of poultry, as this practice was noted to promote the evolution of fluoroquinolone-resistant strains of the bacterium ''[[Campylobacter]]'', a human pathogen.<ref>http://www.fda.gov/cvm/FQWithdrawal.html FDA statement on withdrawal of Baytril for use in poultry</ref> Fluoroquinolones such as [[ciprofloxacin]] are widely used in the treatment of human disease. | ||
| Line 10: | Line 10: | ||
[[Category:Fluoroquinolone antibiotics]] | [[Category:Fluoroquinolone antibiotics]] | ||
[[de:Enrofloxacin]] | [[de:Enrofloxacin]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 02:16, 9 August 2012
|
WikiDoc Resources for Enrofloxacin |
|
Articles |
|---|
|
Most recent articles on Enrofloxacin Most cited articles on Enrofloxacin |
|
Media |
|
Powerpoint slides on Enrofloxacin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Enrofloxacin at Clinical Trials.gov Clinical Trials on Enrofloxacin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Enrofloxacin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Enrofloxacin Discussion groups on Enrofloxacin Patient Handouts on Enrofloxacin Directions to Hospitals Treating Enrofloxacin Risk calculators and risk factors for Enrofloxacin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Enrofloxacin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Enrofloxacin is a fluoroquinolone antibiotic sold by the Bayer Corporation under the trade name Baytril. Enrofloxacin is currently FDA-approved for treatment of individual pets and domestic animals in the United States. In September of 2005, the FDA withdrew approval of Baytril for use in water to treat flocks of poultry, as this practice was noted to promote the evolution of fluoroquinolone-resistant strains of the bacterium Campylobacter, a human pathogen.[1] Fluoroquinolones such as ciprofloxacin are widely used in the treatment of human disease.
References
- ↑ http://www.fda.gov/cvm/FQWithdrawal.html FDA statement on withdrawal of Baytril for use in poultry